FITZGERALD KEVIN JOSEPH (CSO & EVP, Head of Research) sold 12.9% of their position (3.25K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.05M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.69K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−47.00
Price / share
$323.62
Trade value
$15.21K
% of position
Common Stock
Shares
−90.00
Price / share
$324.65
Trade value
$29.22K
% of position
Common Stock
Shares
−258.00
Price / share
$325.63
Trade value
$84.01K
% of position
Common Stock
Shares
−392.00
Price / share
$326.81
Trade value
$128.11K
% of position
Common Stock
Shares
−329.00
Price / share
$327.67
Trade value
$107.80K
% of position
Common Stock
Shares
−100.00
Price / share
$328.71
Trade value
$32.87K
% of position
Common Stock
Shares
−170.00
Price / share
$329.71
Trade value
$56.05K
% of position
Common Stock
Shares
−81.00
Price / share
$330.85
Trade value
$26.80K
% of position
Common Stock
Shares
−94.00
Price / share
$331.93
Trade value
$31.20K
% of position
Common Stock
Shares
−37.00
Price / share
$332.64
Trade value
$12.31K
% of position
Common Stock
Shares
−289.00
Price / share
$316.55
Trade value
$91.48K
% of position
Common Stock
Shares
−282.00
Price / share
$318.62
Trade value
$89.85K
% of position
Common Stock
Shares
−722.00
Price / share
$320.51
Trade value
$231.41K
% of position
Common Stock
Shares
−359.00
Price / share
$321.58
Trade value
$115.45K
% of position
Net shares
+438.00
Net value
-$1.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +3.69K | — | — | 17.2% | 21.42K | 25.11K |
| Common Stock Direct | 3/2/2026 | S · Sale | −47.00 | $323.62 | $15.21K | 0.2% | 25.11K | 25.06K |
| Common Stock Direct | 3/2/2026 | S · Sale | −90.00 | $324.65 | $29.22K | 0.4% | 25.06K | 24.97K |
| Common Stock Direct | 3/2/2026 | S · Sale | −258.00 | $325.63 | $84.01K | 1.0% | 24.97K | 24.71K |
| Common Stock Direct | 3/2/2026 | S · Sale | −392.00 | $326.81 | $128.11K | 1.6% | 24.71K | 24.32K |
| Common Stock Direct | 3/2/2026 | S · Sale | −329.00 | $327.67 | $107.80K | 1.4% | 24.32K | 23.99K |
| Common Stock Direct | 3/2/2026 | S · Sale | −100.00 | $328.71 | $32.87K | 0.4% | 23.99K | 23.89K |
| Common Stock Direct | 3/2/2026 | S · Sale | −170.00 | $329.71 | $56.05K | 0.7% | 23.89K | 23.72K |
| Common Stock Direct | 3/2/2026 | S · Sale | −81.00 | $330.85 | $26.80K | 0.3% | 23.72K | 23.64K |
| Common Stock Direct | 3/2/2026 | S · Sale | −94.00 | $331.93 | $31.20K | 0.4% | 23.64K | 23.55K |
| Common Stock Direct | 3/2/2026 | S · Sale | −37.00 | $332.64 | $12.31K | 0.2% | 23.55K | 23.51K |
| Common Stock Direct | 3/3/2026 | S · Sale | −289.00 | $316.55 | $91.48K | 1.2% | 23.51K | 23.22K |
| Common Stock Direct | 3/3/2026 | S · Sale | −282.00 | $318.62 | $89.85K | 1.2% | 23.22K | 22.94K |
| Common Stock Direct | 3/3/2026 | S · Sale | −722.00 | $320.51 | $231.41K | 3.1% | 22.94K | 22.22K |
| Common Stock Direct | 3/3/2026 | S · Sale | −359.00 | $321.58 | $115.45K | 1.6% | 22.22K | 21.86K |
| Total | +438.00 | -$1.05M | ||||||
Stock Option (right to buy)
Common Stock
8.11K shares
Shares
+8.11K
Strike price
325.07
Held after
8.11K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock8.11K shares | 3/2/2026 | A · Award | +8.11K | 325.07 | — | 8.11K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 537.00 | Indirect |
| Total | 537.00 | 537.00 indirect |